Topic

Pacira Biosciences

Topic

Pacira Biosciences

Viatris Closes $36.50-Per-Share Pacira Acquisition

Viatris closed its $36.50-per-share cash acquisition of Pacira BioSciences after a tender offer drew 66.46% of shares, creating a wholly owned subsidiary in non-opioid pain management.